Estimating the potential impact of implementing pre‐emptive pharmacogenetic testing in primary care across the UK

UK community pharmacy database review found that amongst 19.1-21.1% of all new prescriptions for 56 drugs, an actionable drug–gene interaction (DGI) was present. Authors suggest actionable DGIs frequently occur in UK primary care, with a large opportunity to optimise prescribing.

Source:

British Journal of Clinical Pharmacology